Elicera Therapeutics AB (ELIC) — Financial Flexibility Index
Elicera Therapeutics AB (ELIC) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of Skr-4.74 Million (operating CF Skr-4.74 Million minus capex Skr0.00) represents -1% of total liabilities (Skr6.97 Million). Also explore Elicera Therapeutics AB annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elicera Therapeutics AB Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Elicera Therapeutics AB across 8 annual periods. Check ELIC cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Elicera Therapeutics AB (2017–2024)
Year-by-year free cash flow to debt coverage for Elicera Therapeutics AB. For the full company profile including market capitalisation, see Elicera Therapeutics AB stock valuation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.45x | Skr-23.46 Million | Skr-23.46 Million | Skr6.79 Million | ▼ -219.0% |
| 2023 | -1.08x | Skr-14.92 Million | Skr-14.92 Million | Skr13.78 Million | ▼ -70.7% |
| 2022 | -0.63x | Skr-8.57 Million | Skr-8.57 Million | Skr13.51 Million | ▲ +88.9% |
| 2021 | -5.72x | Skr-14.29 Million | Skr-14.29 Million | Skr2.50 Million | ▼ -1489.8% |
| 2020 | -0.36x | Skr-846.37K | Skr-905.25K | Skr2.35 Million | ▲ +99.4% |
| 2019 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2018 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2017 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | — |